Fuller & Thaler Asset Management
JAZZ icon

Fuller & Thaler Asset Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Fuller & Thaler Asset Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$317M Sell
1,676,142
-990
-0.1% -$173K 1.07% 10
2025
Q4 		$285M Buy
1,677,132
+50,996
+3% +$7.82M 0.96% 9
2025
Q3 		$214M Sell
1,626,136
-2,823
-0.2% -$339K 0.73% 26
2025
Q2 		$173M Buy
1,628,959
+297,948
+22% +$32.4M 0.63% 37
2025
Q1 		$165M Buy
1,331,011
+391,660
+42% +$51.1M 0.64% 37
2024
Q4 		$116M Buy
939,351
+507,234
+117% +$59.8M 0.44% 72
2024
Q3 		$48.1M Sell
432,117
-37,557
-8% -$4.12M 0.19% 169
2024
Q2 		$50.1M Sell
469,674
-615,466
-57% -$67.7M 0.21% 146
2024
Q1 		$131M Buy
+1,085,140
New +$133M 0.57% 54
2016
Q3 		– Sell
-800
Closed -$113K – 795
2016
Q2 		$113K Buy
+800
New +$118K ﹤0.01% 441
2014
Q4 		– Sell
-400
Closed -$64K – 632
2014
Q3 		$64K Sell
400
-400
-50% -$61.5K ﹤0.01% 603
2014
Q2 		$118K Sell
800
-700
-47% -$97.1K 0.01% 564
2014
Q1 		$208K Buy
+1,500
New +$226K 0.01% 428

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Fuller & Thaler Asset Management's JAZZ Position: Q1 2026 in Review

Fuller & Thaler Asset Management reduced its Jazz Pharmaceuticals (JAZZ) stake by 0.06% in Q1 2026, selling an estimated $173K and leaving 1,676,142 shares worth $317M. The position accounts for 1.07% of the portfolio, ranked #10.

Fuller & Thaler Asset Management first reported a position in JAZZ in Q1 2014 and has held it in 13 quarters since. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • Fuller & Thaler Asset Management held 1,676,142 shares of Jazz Pharmaceuticals worth $317M as of Q1 2026.
  • Fuller & Thaler Asset Management sold 990 Jazz Pharmaceuticals shares in Q1 2026, an estimated $173K.
  • Jazz Pharmaceuticals made up 1.07% of Fuller & Thaler Asset Management's portfolio in Q1 2026, its #10 holding.
  • Fuller & Thaler Asset Management first reported a position in Jazz Pharmaceuticals in Q1 2014 and has held it in 13 quarters since.
  • 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Fuller & Thaler Asset Management's 13F filing for Q1 2026, filed 14 May 2026.